Our favorite dividend shares in today’s stock market. Highlighting companies that stand to profit through innovation, mismatches in share price to market potential, or just plain great economics.
(Stocks may be owned by the Sick Economist, or other commentators on this page.)
Dow Chemical makes the stuff that makes the modern world function. It’s likely that you come into contact with Dow’s products each and every day, even if you don’t realize it. Dow manufactures thousands of basic chemicals used in dozens of different industries around the world. Over the decades, Dow has proven to offer a very resilient business model, with high and growing dividends.
Iron Mountain stores paperwork and data for 95% of the Fortune 1000 companies. If information is the lifeblood of commerce, then IRM is essential to the continued survival of Global Business. The company’s legacy business (paper records storage) provides steady and recurring revenue, while the company’s growth businesses (digital storage and services) create the growth that investors need for the 21st century. Structured as a REIT, Iron Mountain constantly puts that growing cash flow right back into investors’ pockets.
Novo Nordisk is one of the world’s premier providers of novel medicines for diabetic&obese patients. With diabetes expected to afflict 750 million people by 2045, Novo is a pure growth play. Lately, the company has launched a new product, Wegovy, that is the first medicine scientifically proven highly efficacious against obesity. This should open a brand new market for Novo, with the potential to eventually sell the medicine to billions of people world wide. Although Novo’s dividend is modest today, the company’s potential for explosive growth could mean a cash flow bonanza for shareholders.